Information Journal Paper
APA:
Copy. (2018). CSL112 (Apolipoprotein AI [Human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, 38(4), 953-963. SID. https://sid.ir/paper/704268/en
Vancouver:
Copy. CSL112 (Apolipoprotein AI [Human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients. ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY[Internet]. 2018;38(4):953-963. Available from: https://sid.ir/paper/704268/en
IEEE:
Copy, “CSL112 (Apolipoprotein AI [Human]) enhances cholesterol efflux similarly in healthy individuals and stable atherosclerotic disease patients,” ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, vol. 38, no. 4, pp. 953–963, 2018, [Online]. Available: https://sid.ir/paper/704268/en